Uso da inseminação artificial em tempo fixo (IATF) em bubalinos criados em sistema de produção na várzea no estado do Amapá

Incrementa o uso da Inseminação Artificial em Tempo Fixo (IATF) em búfalas criadas em sistema produtivo extensivo de terras alagadas sazonalmente. O experimento realizado na cidade de Itaubal, no estado do Amapá, mais precisamente na Fazenda Motogeral LTDA, no período de novembro de 2004 a fevereiro de 2005, na estação favorável à reprodução. A propriedade possui um rebanho bubalino mestiço, onde predomina as raças Mediterrâneo e Murrah. Os animais possuem idade média de seis anos, em sua maioria plurípara e todas amamentando. Utilizou-se 93 animais, sendo que 70 animais sincronizados e inseminados em tempo fixo e 23 animais como grupo controle. Todos os animais foram previamente selecionados através de exame ginecológico e escore de condição corporal (ECC). Os animais sincronizados dividiram-se em três grupos: No grupo 1 (G1) com 20 animais utilizou-se o protocolo ovsynch; No grupo 2 (G2) com 29 animais utilizou-se o protocolo DIB-synch; e no grupo 3 (G3), 21 animais compuseram o grupo denominado CLsynch. E os não sincronizados compuseram o grupo controle ou Grupo 4 (G4) composto por 23 animais que foram inseminados 12h após a visualização do cio. Das 93 búfalas inseminadas 52 (55,91%) tornaram-se gestantes. Das 70 búfalas sincronizadas e inseminadas em tempo pré-determinado 43 (61,43%) ficaram gestantes. No G1 12 (60%) búfalas ficaram gestantes, no G2 19 (65,5%) búfalas ficaram gestantes e no G3 12 (57,14%) búfalas ficaram gestantes. No grupo controle a taxa de prenhez foi de 39,13%. Não houve diferença significativa entre os grupos sincronizados e o grupo controle (P=0,27; X²=3,86). Nos grupos sincronizados não se observou diferença significativa entre os grupos (P=0,82; X² =0,38). As variáveis presença de muco (P= 4,11; Fisher=0,99) e contratilidade uterina (P=8,65; Fisher=0,99) influenciaram significativamente na taxa de prenhez. Dos 70 animais sincronizados 34 (48,57%) apresentaram muco e 54 (77,14%) apresentaram contratilidade uterina durante a IATF. Quanto ao ECC apesar de estatisticamente não ter influencia nos resultados, notou-se que os animais com ECC• 2.5 apresentaram as maiores taxas de prenhez. Pode-se concluir que os protocolos utilizados mostram que a IATF em bubalinos, criados de forma extensiva em áreas pantanosas, são uma alternativa promissora para melhorar a eficiência reprodutiva desta espécie na região Amazônica. O protocolo CL-synch precisa de mais estudos, com maior número de animais. Os custos dos tratamentos, não inviabilizam a adoção da técnica em propriedades rurais com sistema de produção extensiva.

Efeitos da exposição perinatal ao chumbo sobre a pressão arterial e a rea tividade vascular de ratos recém-desmamados e adultos, tratados ou não com DMSA, L-Arginina e/ou Enalapril: Andréia Fresneda Gaspar. -

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Comparação da análise miográfica sonora com a força muscular

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Influência das alterações degenerativas endometriais e da idade hemodinâmica do trato reprodutivo de éguas após a inseminação artificial e durante as fases iniciais do desenvolvimento embrionário

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Different patterns between mechanical and electrical activities: an approach to investigate gastric motility in a model of long-term diabetic rats

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Antidiarrheal and intestinal antiinflammatory activities of a methanolic extract of Qualea parviflora Mart. in experimental models

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Perfil gênico no oviduto bovino de fêmeas Nelore e Aberdeen angus

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Ivabradine: Just another New Pharmacological Option for Heart Rate Control?

Ivabradine (IVB) is a heart rate lowering agent that acts via selective inhibition of the pacemaker funny current in sinoatrial nodal P cells, thus, reducing heart rate at rest and during exercise with minimal effect on myocardial contractility, blood pressure, and intracardiac conduction. IVB exerts no effect on external respiratory function parameters and it may also play a role in patients with concurrent chronic obstructive pulmonary disease. This property constitutes an important advantage over β-blockers. IVB acts by reducing the heart rate in a mechanism different from β-blockers, calcium channel blockers or late sodium channel blockers, three commonly prescribed antianginal drugs. As clinical trials have shown, it is remarkably well-tolerated and offers an alternative for patients who cannot take β-blockers. The combination of IVB and atenolol at commonly used doses in patients with chronic stable angina produced additional efficacy with no untoward effect on safety or tolerability. Additionally, side effects are rare and largely limited to a luminous phenomenon or phosphenes. This sensation is thought to be due to a block of Ih in the retina, a current very similar to cardiac If channels. IVB is contraindicated in patients with sick sinus syndrome or sinus node dysfunction and in patients taking hepatic inhibitors of Cytochrome P450 family 3, subfamily A, polypeptide 4 (abbreviated CYP3A4), with exception of omeprazole or lansoprazole. This review briefly summarizes the main studies regarding this drug.

Renal and vascular effects of Crotalus durissus cumanensis venom and its crotoxin fraction

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Alternate current biosusceptometry for the assessment of gastric motility after proximal gastrectomy in rats: a feasibility study

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Transthoracic cardiac ultrasonic stimulation induces a negative chronotropic effect

The objective of this study is to investigate cardiac bioeffects resulting from ultrasonic stimulation using a specific set of acoustical parameters. Ten Sprague-Dawley rats were anesthetized and exposed to 1-MHz ultrasound pulses of 3-MPa peak rarefactional pressure and approximately 1% duty factor. The pulse repetition frequency started slightly above the heart rate and was decreased by 1 Hz every 10 s, for a total exposure duration of 30 s. The control group was composed of five rats. Two-way analysis of variance for repeated measures and Bonferroni post hoc tests were used to compare heart rate and ejection fraction, which was used as an index of myocardial contractility. It was demonstrated for the first time that transthoracic ultrasound has the potential to decrease the heart rate by similar to 20%. The negative chronotropic effect lasted for at least 15 min after ultrasound exposure and there was no apparent gross damage to the cardiac tissue.

Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats

Activation of TLRs (Toll-like receptors) induces gene expression of proteins involved in the immune system response. TLR4 has been implicated in the development and progression of CVDs (cardiovascular diseases). Innate and adaptive immunity contribute to hypertension-associated end-organ damage, although the mechanism by which this occurs remains unclear. In the present study, we hypothesize that inhibition of TLR4 decreases BP (blood pressure) and improves vascular contractility in resistance arteries from SHR (spontaneously hypertensive rats). TLR4 protein expression in mesenteric resistance arteries was higher in 15-week-old SHR than in age-matched Wistar controls or in 5-week-old SHR. To decrease the activation of TLR4, 15-week-old SHR and Wistar rats were treated with anti-TLR4 (anti-TLR4 antibody) or non-specific IgG control antibody for 15 days (1 mu g per day, intraperitoneal). Treatment with anti-TLR4 decreased MAP (mean arterial pressure) as well as TLR4 protein expression in mesenteric resistance arteries and IL-6 (interleukin 6) serum levels from SHR when compared with SHR treated with IgG. No changes in these parameters were found in treated Wistar control rats. Mesenteric resistance arteries from anti-TLR4-treated SHR exhibited decreased maximal contractile response to NA (noradrenaline) compared with IgG-treated SHR. Inhibition of COX (cyclo-oxygenase)-1 and COX-2, enzymes related to inflammatory pathways, decreased NA responses only in mesenteric resistance arteries of SHR treated with IgG. COX-2 expression and TXA(2) (thromboxane A(2)) release were decreased in SHR treated with anti-TLR4 compared with IgG-treated SHR. Our results suggest that TLR4 activation contributes to increased BP, low-grade inflammation and plays a role in the augmented vascular contractility displayed by SHR.

Comparative experimental study of myocardial protection with crystalloid solutions for heart transplantation

Background: There is a growing need to improve myocardial protection, which will lead to better performance of cardiac operations and reduce morbidity and mortality. Therefore, the objective of this study was to compare the efficacy of myocardial protection solution using both intracellular and extracellular crystalloid type regarding the performance of the electrical conduction system, left ventricular contractility and edema, after being subjected to ischemic arrest and reperfusion. Methods: Hearts isolated from male Wistar (n=32) rats were prepared using Langendorff method and randomly divided equally into four groups according the cardioprotective solutions used Krebs-Henseleit-Buffer (KHB), Bretschneider-HTK (HTK), St. Thomas-1 (STH-1) and Celsior (CEL). After stabilization with KHB at 37 degrees C, baseline values (control) were collected for heart rate (HR), left ventricle systolic pressure (LVSP), maximum first derivate of rise left ventricular pressure (+dP/dt), maximum first derivate of fall left ventricular pressure (-dP/dt) and coronary flow (CF). The hearts were then perfused at 10 degrees C for 5 min and kept for 2 h in static ischemia at 20 degrees C in each cardioprotective solution. Data evaluation was done using analysis of variance in completely randomized One-Way ANOVA and Tukey's test for multiple comparisons. The level of statistical significance chosen was P<0.05. Results: HR was restored with all the solutions used. The evaluation of left ventricular contractility (LVSP, +dP/dt and -dP/dt) showed that treatment with CEL solution was better compared to other solutions. When analyzing the CF, the HTK solution showed better protection against edema. Conclusion: Despite the cardioprotective crystalloid solutions studied are not fully able to suppress the deleterious effects of ischemia and reperfusion in the rat heart, the CEL solution had significantly higher results followed by HTK>KHB>STH-1.

Diaphragmatic pacing stimulation in spinal cord injury: anesthetic and perioperative management

OBJECTIVE: The standard therapy for patients with high-level spinal cord injury is long-term mechanical ventilation through a tracheostomy. However, in some cases, this approach results in death or disability. The aim of this study is to highlight the anesthetics and perioperative aspects of patients undergoing insertion of a diaphragmatic pacemaker. METHODS: Five patients with quadriplegia following high cervical traumatic spinal cord injury and ventilator-dependent chronic respiratory failure were implanted with a laparoscopic diaphragmatic pacemaker after preoperative assessments of their phrenic nerve function and diaphragm contractility through transcutaneous nerve stimulation. ClinicalTrials.gov:NCT01385384. RESULTS: The diaphragmatic pacemaker placement was successful in all of the patients. Two patients presented with capnothorax during the perioperative period, which resolved without consequences. After six months, three patients achieved continuous use of the diaphragm pacing system, and one patient could be removed from mechanical ventilation for more than 4 hours per day. CONCLUSIONS: The implantation of a diaphragmatic phrenic system is a new and safe technique with potential to improve the quality of life of patients who are dependent on mechanical ventilation because of spinal cord injuries. Appropriate indication and adequate perioperative care are fundamental to achieving better results.